ANTI-CLDN18.2 ANTIBODY CONJUGATES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240307564A1
SERIAL NO

18546980

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides herein conjugates of anti-CLDN18.2 antibodies or antigen-binding fragments thereof with radionuclides, the pharmaceutical composition containing the same and the uses thereof in imaging, patient screening, treatment process monitoring and efficacy evaluation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BEIJING CANCER HOSPITAL52 FUCHENG ROAD HAIDIAN DISTRICT BEIJING 100142
SUZHOU TRANSCENTA THERAPEUTICS CO LTDSUZHOU JIANGSU 215123

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DING, Jin Beijing, CN 8 34
GU, Yi Suzhou, Jiangsu, CN 35 64
LI, Hongjun Suzhou, Jiangsu, CN 48 933
QIAN, Xueming Suzhou, Jiangsu, CN 25 195
TENG, Fei Suzhou, Jiangsu, CN 41 203
WANG, Feng Beijing, CN 857 9908
YANG, Zhi Beijing, CN 88 575
ZHU, Hua Beijing, CN 66 325

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation